Cargando…

State-of-the-Art Methods and Emerging Fluid Biomarkers in the Diagnostics of Dementia—A Short Review and Diagnostic Algorithm

The most common neurodegenerative dementias include Alzheimer’s disease (AD), dementia with Lewy bodies (DLB), and frontotemporal dementia (FTD). The correct etiology-based diagnosis is pivotal for clinical management of these diseases as well as for the suitable timing and choosing the accurate dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solje, Eino, Benussi, Alberto, Buratti, Emanuele, Remes, Anne M., Haapasalo, Annakaisa, Borroni, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145467/ https://www.ncbi.nlm.nih.gov/pubmed/33925655 http://dx.doi.org/10.3390/diagnostics11050788

Ejemplares similares

Modifiable potential risk factors in familial and sporadic frontotemporal dementia
por: Soppela, Helmi, et al.
Publicado: (2022)

Prodromal and Early bvFTD: Evaluating Clinical Features and Current Biomarkers
por: Katisko, Kasper, et al.
Publicado: (2019)

Brainstem atrophy is linked to extrapyramidal symptoms in frontotemporal dementia
por: Heikkinen, Sami, et al.
Publicado: (2022)

Deficient neurotransmitter systems and synaptic function in frontotemporal lobar degeneration—Insights into disease mechanisms and current therapeutic approaches
por: Huber, Nadine, et al.
Publicado: (2021)

Experimental Disease-Modifying Agents for Frontotemporal Lobar Degeneration
por: Giunta, Marcello, et al.
Publicado: (2021)

Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders
por: Katisko, Kasper, et al.
Publicado: (2019)

Astrocytes and Microglia as Potential Contributors to the Pathogenesis of C9orf72 Repeat Expansion-Associated FTLD and ALS
por: Rostalski, Hannah, et al.
Publicado: (2019)

Serum total TDP-43 levels are decreased in frontotemporal dementia patients with C9orf72 repeat expansion or concomitant motoneuron disease phenotype
por: Katisko, Kasper, et al.
Publicado: (2022)

Serum neurofilament light chain in FTLD: association with C9orf72, clinical phenotype, and prognosis
por: Cajanus, Antti, et al.
Publicado: (2020)

FTLD Patient–Derived Fibroblasts Show Defective Mitochondrial Function and Accumulation of p62
por: Leskelä, Stina, et al.
Publicado: (2021)

Toward a Glutamate Hypothesis of Frontotemporal Dementia
por: Benussi, Alberto, et al.
Publicado: (2019)

Peripheral inflammatory markers and clinical correlations in patients with frontotemporal lobar degeneration with and without the C9orf72 repeat expansion
por: Katisko, Kasper, et al.
Publicado: (2019)

BV-2 Microglial Cells Overexpressing C9orf72 Hexanucleotide Repeat Expansion Produce DPR Proteins and Show Normal Functionality but No RNA Foci
por: Rostalski, Hannah, et al.
Publicado: (2020)

Salivary Metabolomics in the Diagnosis and Monitoring of Neurodegenerative Dementia
por: Hyvärinen, Eelis, et al.
Publicado: (2023)

Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia
por: Forlenza, Orestes V., et al.
Publicado: (2015)

Low Serum High-Density Lipoprotein Cholesterol Levels Associate with the C9orf72 Repeat Expansion in Frontotemporal Lobar Degeneration Patients
por: Jääskeläinen, Olli, et al.
Publicado: (2019)

Low Cerebrospinal Fluid Amyloid-Beta Concentration Is Associated with Poorer Delayed Memory Recall in Women
por: Haapalinna, Fanni, et al.
Publicado: (2016)

Frontotemporal dementia as a comorbidity to idiopathic normal pressure hydrocephalus (iNPH): a short review of literature and an unusual case
por: Korhonen, V. E., et al.
Publicado: (2017)

Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia
por: Benussi, Alberto, et al.
Publicado: (2015)

Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics
por: Teunissen, Charlotte E., et al.
Publicado: (2016)

The Association Between Distinct Frontal Brain Volumes and Behavioral Symptoms in Mild Cognitive Impairment, Alzheimer's Disease, and Frontotemporal Dementia
por: Cajanus, Antti, et al.
Publicado: (2019)

Transcranial magnetic stimulation and amyloid markers in mild cognitive impairment: impact on diagnostic confidence and diagnostic accuracy
por: Padovani, Alessandro, et al.
Publicado: (2019)

Added Diagnostic Value of Cerebrospinal Fluid Biomarkers for Differential Dementia Diagnosis in an Autopsy-Confirmed Cohort
por: Niemantsverdriet, Ellis, et al.
Publicado: (2018)

Patient-derived skin fibroblasts as a model to study frontotemporal lobar degeneration
por: Hoffmann, Dorit, et al.
Publicado: (2022)

Biomarkers in Oral Fluids as Diagnostic Tool for Psoriasis
por: Jiménez, Constanza, et al.
Publicado: (2022)

C9orf72 Proteins Regulate Autophagy and Undergo Autophagosomal or Proteasomal Degradation in a Cell Type-Dependent Manner
por: Leskelä, Stina, et al.
Publicado: (2019)

Circulating Exosome microRNAs as Diagnostic Biomarkers of Dementia
por: Dong, Xiaoyu, et al.
Publicado: (2020)

Autopsy-diagnosed neurodegenerative dementia cases support the use of cerebrospinal fluid protein biomarkers in the diagnostic work-up
por: Bruzova, Magdalena, et al.
Publicado: (2021)

Development of a brief assessment and algorithm for ascertaining dementia in low-income and middle-income countries: the 10/66 short dementia diagnostic schedule
por: Stewart, Robert, et al.
Publicado: (2016)

Automatic MRI Quantifying Methods in Behavioral-Variant Frontotemporal Dementia Diagnosis
por: Cajanus, Antti, et al.
Publicado: (2018)

Mutations of Pre-mRNA Splicing Regulatory Elements: Are Predictions Moving Forward to Clinical Diagnostics?
por: Grodecká, Lucie, et al.
Publicado: (2017)

Biomarkers of Dementia with Lewy Bodies: Differential Diagnostic with Alzheimer’s Disease
por: Bousiges, Olivier, et al.
Publicado: (2022)

Diagnostic algorithm for determining primary tumor sites using peritoneal fluid
por: Park, Cheol Keun, et al.
Publicado: (2018)

The Phenotype of the C9ORF72 Expansion Carriers According to Revised Criteria for bvFTD
por: Solje, Eino, et al.
Publicado: (2015)

The impact of transcranial magnetic stimulation on diagnostic confidence in patients with Alzheimer disease
por: Benussi, Alberto, et al.
Publicado: (2018)

Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases
por: Schmitz, Matthias, et al.
Publicado: (2022)

Diagnostic biomarkers in tear fluid: from sampling to preanalytical processing
por: Bachhuber, Franziska, et al.
Publicado: (2021)

Role and Relevance of Cerebrospinal Fluid Cells in Diagnostics and Research: State-of-the-Art and Underutilized Opportunities
por: Otto, Ferdinand, et al.
Publicado: (2021)

Diagnostic performance of new and classic CSF biomarkers in age-related dementias
por: Marchegiani, Francesca, et al.
Publicado: (2019)

Prodromal frontotemporal dementia: clinical features and predictors of progression
por: Benussi, Alberto, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qn2nchldkspu62ajummanlf4ve